Skip to main content
Novartis
language-selector-globe Italia | it
Siti Novartis
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Italia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Chi siamo 
      • Novartis in Italia 
      • La nostra missione 
      • Aree di attività 
        • Aree terapeutiche 
      • Diversity & Inclusion 
      • La nostra storia 
        • Le nostre origini 
        • Dal 1996 a oggi 
      • Persone 
      viale affollato Chi siamo
    • Per il paziente 
      • Il nostro impegno 
      • Alleati per la Salute 
        • Politiche Sanitarie e Socio Assistenziali 
        • A fianco di chi aiuta 
        • Benessere psicofisico 
        • News dalle Associazioni Pazienti 
        • Mini Lessons EUPATI 
        • Servizi e materiali utili 
        • Novartis Influencer Masterclass for Patients 
        • HTA - Nuovo regolamento 
        • Attualità 
      • Informazione e sensibilizzazione 
        • Campagne di informazione e sensibilizzazione 
      • Linea Embrace per la gestione delle malattie croniche 
      • Segnalazione effetti indesiderati 
      Un medico tiene le mani a un paziente Per il paziente
    • Sostenibilità 
      • Sostenibilità ambientale 
      • Etica e compliance 
      • Diversity & Inclusion 
      • Accesso e diritto alla salute 
      • Salute globale 
      • Reporting 
      • Indici ESG 
      Young patients waiting outside hospital in Rwanda Sostenibilità
    • Ricerca e innovazione 
      • Ricerca & sviluppo 
      • Nuove frontiere della R&S 
      • Novartis, la ricerca clinica in Italia nel 2023 
      • Open Innovation 
      • Professionisti della salute 
      dettaglio di una confezione di pillole Ricerca e innovazione
    • Lavora con noi 
      • Opportunità di lavoro 
      • Come lavoriamo 
      • Benessere 
      • Benefit 
      • Diversity & Inclusion 
      • Riconoscimenti e certificazioni 
      • La nostra cultura 
      Lavora con noi Lavora con noi
    • News 
      • Fatti e notizie 
      • Area riservata ai giornalisti 
      • Comunicati stampa 
      News News
    • Contatti 
    Homepage Italia Home
  1. Home
  2. Lavora con noi
  3. Cerca offerte di lavoro
  • Sort by Sort ascending
  • Titolo di lavoro
  • Site
  • Posizione
  • Divisione
  • Business
  • Area funzionale
  • Data di pubblicazione Sort descending
Titolo di lavoro Site Posizione Divisione Business Area funzionale Data di pubblicazione Sort descending
Sr. Bus. Analyst DDIT US&I CPM Hyderabad (Office) India Operations CTS Technology Transformation Apr 17, 2024
Sr. Spec. DDIT ISC SecOps IAM Hyderabad (Office) India Operations CTS Technology Transformation Apr 17, 2024
Customer Engagement Specialist Lithuania Lituania International Innovative Medicines I saldi Apr 18, 2024
Healthcare Solutions Lead Lithuania Lituania International Innovative Medicines Marketing Apr 18, 2024
Medical Science Liaison Lead Warsaw Polonia International Innovative Medicines Research & Development Apr 18, 2024
MSL Manager, RLT Shanghai (Shanghai) Cina International Innovative Medicines Research & Development Apr 18, 2024
(高级)医药代表 /(资深)产品主管 Chongqing (Chongqing Province) Cina International Innovative Medicines I saldi Apr 18, 2024
Mgr. DDIT Svc.Mgt China Dalian (Liaoning Province) Cina Operations CTS Technology Transformation Apr 21, 2024
Sr. Mgr. DDIT Svc.Mgt CN Data Platf Dalian (Liaoning Province) Cina Operations CTS Technology Transformation Apr 21, 2024
Sr. Mgr. DDIT Sol.Del. China Data Dalian (Liaoning Province) Cina Operations CTS Technology Transformation Apr 21, 2024
Sachkundige Person Radiopharmazie (d/w/m) Munich (AAA Germany GmbH) Germania Operations Innovative Medicines Quality Apr 22, 2024
Sr. Spec. DDIT IES NW Engineering Hyderabad (Office) India Operations CTS Technology Transformation Apr 22, 2024
Snr.Spec. DDIT APD Sol Del Visualization Hyderabad (Office) India Operations CTS Technology Transformation Apr 22, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) Cina International Innovative Medicines I saldi Apr 22, 2024
Sr. Specialist DDIT APD ERP PlatformTech Hyderabad (Office) India Operations CTS Technology Transformation Apr 23, 2024
Therapeutic Area Partner - Kuwait Kuwait Kuwait International Innovative Medicines I saldi Apr 23, 2024
Senior Medical Information Manager 2 Dublin (Novartis Corporate Center (NOCC)) Irlanda Operations CTS Research & Development Apr 23, 2024
Innovation Manager Hyderabad (Office) India Operations Innovative Medicines Quality Apr 24, 2024
Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Apr 24, 2024
Principal Scientist Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Apr 24, 2024
Senior Scientist II Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Apr 24, 2024
Clinical Development Medical Director East Hanover USA Development Innovative Medicines Research & Development Apr 24, 2024
Medical Science Liaison Allergy / Derm MN, WI, ND, SD Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development Apr 25, 2024
Manufacturing Specialist Changping County (Beijing) Cina Operations Innovative Medicines Technical Operations Apr 26, 2024
Analyst Hyderabad (Office) India Operations CTS Marketing Apr 28, 2024
县域主任(主管) Honghe (Yunnan Province) Cina International Innovative Medicines I saldi Apr 28, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) Cina International Innovative Medicines I saldi Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) Cina International Innovative Medicines I saldi Apr 29, 2024
MSL Tumeurs Solides - Nord Est Field Non-Sales (France) Francia International Innovative Medicines Research & Development Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) Cina International Innovative Medicines I saldi Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) Cina International Innovative Medicines I saldi Apr 29, 2024
Senior Brand Manager Shanghai (Shanghai) Cina International Innovative Medicines Marketing Apr 29, 2024
Maintenance & Calibration Technician (2nd shift) Millburn USA Operations Innovative Medicines Technical Operations Apr 29, 2024
Assoc. Dir. DDIT OPX Planning Prague Repubblica Ceca Operations CTS Technology Transformation Apr 29, 2024
Oncology Specialist - RLT- Portland- Remote Field Sales (USA) USA US Innovative Medicines I saldi Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) Cina International Innovative Medicines I saldi Apr 29, 2024
Analyst Hyderabad (Office) India Operations CTS Marketing Apr 29, 2024
MR Beijing (Beijing) Cina International Innovative Medicines I saldi Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) Cina International Innovative Medicines I saldi Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) Cina International Innovative Medicines I saldi Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) Cina International Innovative Medicines I saldi Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) Cina International Innovative Medicines I saldi Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) Cina International Innovative Medicines I saldi Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) Cina International Innovative Medicines I saldi Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) Cina International Innovative Medicines I saldi Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Yinchuan (Ningxia Province) Cina International Innovative Medicines I saldi Apr 29, 2024
Area Marketing Manager Chengdu (Sichuan Province) Cina International Innovative Medicines Marketing Apr 30, 2024
(高级)区域市场经理 Zhengzhou (Henan Province) Cina International Innovative Medicines Marketing Apr 30, 2024
Cybersecurity Solutions Architect (Global Drug Development Team) Prague Repubblica Ceca Operations CTS Technology Transformation Apr 30, 2024
Snr Spec. DDIT US&I D&A Operations Hyderabad (Office) India Operations CTS Technology Transformation Apr 30, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122

Novartis Italia

Naviga
  • Per il paziente
  • Professionisti della salute
  • Sostenibilità
  • News
  • Lavora con noi
  • Novartis nel mondo
News
  • Archivio news
  • Fatti & Notizie
  • Comunicati Stampa
  • Area riservata ai giornalisti
Siti web Novartis
  • Sito del gruppo
Footer Bottom
© 2024 Novartis Italia
  • Avvertenze legali
  • Privacy Policy
  • Contatti
  • Impostazioni cookie
  • Mappa del sito
  • Accessibilità
Elenco siti Novartis
Questo sito è destinato a utenti residenti in Italia